Issued Patents All Time
Showing 1–25 of 26 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12383589 | Synthetic oncolytic LNP-replicon RNA and uses for cancer immunotherapy | Darrell J. Irvine, Ron Weiss, Yingzhong Li, Noor Momin, Yizhou Dong | 2025-08-12 |
| 12295986 | Combination immunotherapy for treatment of melanoma, colon or non-small cell lung cancers | Chensu Wang, Darrell J. Irvine | 2025-05-13 |
| 12258679 | Polyclonal mixtures of antibodies, and methods of making and using them | Laura M. Walker, Eric Krauland | 2025-03-25 |
| 12227559 | Collagen-localized immunomodulatory molecules and methods thereof | Noor Momin, Joseph Palmeri, Magnolia CHINN | 2025-02-18 |
| 11970542 | Bispecific antibodies specific for treating hematological malignancies | Damian J. Green, Yukang Lin, Oliver W. Press, Alice Tzeng | 2024-04-30 |
| 11858993 | Multi-specific antibodies with affinity for human A33 antigen and DOTA metal complex and uses thereof | Sarah M. Cheal, Hong Xu, Steven M. Larson, Nai-Kong V. Cheung, Alice Tzeng | 2024-01-02 |
| 11717548 | Synthetic oncolytic LNP-replicon RNA and uses for cancer immunotherapy | Darrell J. Irvine, Ron Weiss, Yingzhong Li, Noor Momin, Yizhou Dong | 2023-08-08 |
| 11642409 | Immunomodulatory fusion protein-metal hydroxide complexes and methods thereof | Darrell J. Irvine, Tyson Moyer, Yash Agarwal | 2023-05-09 |
| 11485781 | Multiple specificity binders of CXC chemokines | Alessandro Angelini, Andrew Luster | 2022-11-01 |
| 11459389 | Monoclonal antibodies that bind human CD161 | Kai W. Wucherpfennig, Byong Ha Kang, Nathan D. Mathewson | 2022-10-04 |
| 11448643 | Methods to specifically profile protease activity at lymph nodes | Sangeeta N. Bhatia, Darrell J. Irvine, Andrew David Warren, Jaideep S. Dudani, Naveen Mehta | 2022-09-20 |
| 11390964 | Polyclonal mixtures of antibodies, and methods of making and using them | Laura M. Walker, Eric Krauland | 2022-07-19 |
| 11235032 | Combination immunotherapy dosing regimen for immune checkpoint blockade | Chensu Wang, Darrell J. Irvine | 2022-02-01 |
| 11096989 | Synergistic tumor treatment with an extended pharmacokinetic IL-2 and integrin-binding-Fc fusion protein | Jennifer R. Cochran, Byron Hua Kwan | 2021-08-24 |
| 10988534 | Multi-specific antibodies with affinity for human A33 antigen and DOTA metal complex and uses thereof | Sarah M. Cheal, Hong Xu, Steven M. Larson, Nai-Kong V. Cheung, Alice Tzeng | 2021-04-27 |
| 10888603 | Methods of treating cancer cells expressing tumor-associated integrins | Darrell J. Irvine, Cary Francis OPEL, Kelly Dare MOYNIHAN, Jennifer R. Cochran, Byron Hua Kwan | 2021-01-12 |
| 10684289 | Polyclonal mixtures of antibodies, and methods of making and using them | Laura M. Walker, Eric Krauland | 2020-06-16 |
| 10603358 | Combination tumor treatment with an integrin-binding-Fc fusion protein and immune stimulator | Jennifer R. Cochran | 2020-03-31 |
| 10350266 | Method of treating cancer with a multiple integrin binding Fc fusion protein | Jennifer R. Cochran | 2019-07-16 |
| 10166273 | Synergistic tumor treatment with antibodies targeting PD-1, PD-L1 or CTLA4 and integrin-binding-Fc-fusion protein | Jennifer R. Cochran, Byron Hua Kwan | 2019-01-01 |
| 9844582 | Synergistic tumor treatment with extended-PK IL-2 and therapeutic agents | Byron Hua Kwan, Shuning Gai | 2017-12-19 |
| 9464136 | Antibody-based constructs directed against tyrosine kinase receptors | Jamie Spangler, Benjamin Ezra Epstein, Brian L. Ross | 2016-10-11 |
| 8648176 | Engineered proteins with high affinity for DOTA chelates | Kelly Davis Orcutt | 2014-02-11 |
| 8450247 | Cell display libraries | Beau Peelle, Angela M. Belcher, Eric Krauland | 2013-05-28 |
| 8349311 | Mutant interleukin-2 (IL-2) polypeptides | Balaji Rao, Douglas A. Lauffenburger | 2013-01-08 |